Electronegative LDL From Normolipemic Subjects Induces IL-8 and Monocyte Chemotactic Protein Secretion by Human Endothelial Cells

Abstract

Abstract —The presence in plasma of an electronegative LDL subfraction [LDL(−)] cytotoxic for endothelial cells (ECs) has been reported. We studied the effect of LDL(−) on the release by ECs of molecules implicated in leukocyte recruitment [interleukin-8 (IL-8) and monocyte chemotactic protein-1 (MCP-1)] and in the plasminogen activator inhibitor-1 (PAI-1). LDL(−), isolated by anion-exchange chromatography, differed from nonelectronegative LDL [LDL(+)] in its higher triglyceride, nonesterified fatty acid, apoprotein E and apoprotein C-III, and sialic acid contents. No evidence of extensive oxidation was found in LDL(−); its antioxidant and thiobarbituric acid–reactive substances contents were similar to those of LDL(+). However, conjugated dienes were increased in LDL(−), which suggests that mild oxidation might affect these particles. LDL(−) increased, in a concentration-dependent manner, the release of IL-8 and MCP-1 by ECs and was a stronger inductor of both chemokines than oxidized LDL (oxLDL) or LDL(+). PAI-1 release increased slightly in ECs incubated with both LDL(−) and oxLDL but not with LDL(+). However, no cytotoxic effects of LDL(−) were observed on ECs. Actinomycin D inhibited the release of IL-8 and MCP-1 induced by LDL(−) and oxLDL by up to 80%, indicating that their production is mediated by protein synthesis. Incubation of ECs with N -acetyl cysteine inhibited production of IL-8 and MCP-1 induced by LDL(−) and oxLDL by >50%. The free radical scavenger butylated hydroxytoluene slightly inhibited the effect of oxLDL but did not modify the effect of LDL(−). An antagonist (BN-50730) of the platelet-activating factor receptor inhibited production of both chemokines by LDL(−) and oxLDL in a concentration-dependent manner. Our results indicate that LDL(−) shows proinflammatory activity on ECs and may contribute to early atherosclerotic events.